What is the first line treatment for chronic tension-type headache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Chronic Tension-Type Headache

The first-line treatment for chronic tension-type headache is ibuprofen (400 mg) or acetaminophen (1000 mg) for acute management, with amitriptyline (50-100 mg daily) as the first-line preventive therapy for patients with frequent headaches. 1, 2

Acute Treatment Options

First-Line Medications

  • Ibuprofen (400 mg) - Recommended as first-line therapy with strong evidence for effectiveness in providing pain relief at 2 hours 1, 2
  • Acetaminophen (1000 mg) - Equally effective first-line option with demonstrated statistically significant improvement in pain-free response at 2 hours 1, 2
    • Important note: Lower doses of acetaminophen (500-650 mg) do not show statistically significant improvement 1

Key Considerations for Acute Treatment

  • Maximum daily acetaminophen dose should not exceed 4000 mg 2
  • Limit use of acute medications to no more than twice weekly to prevent medication overuse headache 2
  • Avoid opioids and butalbital-containing medications due to high risk of dependency and medication overuse headache 2

Preventive Treatment

First-Line Preventive Therapy

  • Amitriptyline (50-100 mg daily) - Recommended as first-line preventive therapy for chronic tension-type headache 1, 2, 3
    • Significantly reduces monthly headache days 1
    • Produces clinically significant improvements in headache index scores in approximately 38% of patients 3

Cautions with Amitriptyline

  • Monitor for anticholinergic adverse effects, especially in:
    • Older patients
    • Patients with multiple cardiac comorbidities
    • Risk of overdose 1

Alternative Preventive Options

  • If amitriptyline is ineffective or not tolerated, consider:
    • Nortriptyline (up to 75 mg/day) 3
    • Mirtazapine 4
    • Venlafaxine 4

Non-Pharmacological Approaches

Evidence-Based Non-Pharmacological Therapies

  • Physical therapy - Recommended for management of tension-type headache (weak for recommendation) 1, 2
  • Aerobic exercise or progressive strength training - Recommended for prevention (weak for recommendation) 1, 2
  • Stress management therapy - Demonstrated efficacy similar to tricyclic antidepressants 3
    • Combined therapy (stress management + tricyclic antidepressants) produces clinically significant reductions in headache index scores in 64% of patients compared to 38% with medication alone 3

Additional Non-Pharmacological Approaches

  • Resting in a dark, quiet room
  • Adequate hydration
  • Sleep hygiene optimization
  • Tracking headache patterns and identifying triggers 2

Treatment Algorithm

  1. For acute headache episodes:

    • Start with ibuprofen 400 mg or acetaminophen 1000 mg
    • Limit use to no more than twice weekly
  2. For patients with frequent headaches (>2 per week):

    • Initiate preventive therapy with amitriptyline, starting at low dose (10-25 mg) and titrating up to 50-100 mg daily as tolerated
    • Add non-pharmacological approaches (physical therapy, aerobic exercise, stress management)
  3. For patients not responding to amitriptyline:

    • Consider alternative preventive medications (mirtazapine, venlafaxine)
    • Intensify non-pharmacological approaches
  4. For optimal results in patients with chronic tension-type headache:

    • Consider combination therapy with both medication and non-pharmacological approaches, which has shown superior results to either approach alone 3

Common Pitfalls to Avoid

  • Using acetaminophen at doses lower than 1000 mg, which lacks evidence for efficacy 1
  • Overuse of acute medications leading to medication overuse headache 2
  • Using onabotulinumtoxinA for chronic tension-type headache, which is not recommended (weak against recommendation) 1
  • Failure to monitor for anticholinergic side effects with amitriptyline, particularly in vulnerable populations 1
  • Relying solely on pharmacological or non-pharmacological approaches when combination therapy shows superior results 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tension-Type Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treating tension-type headache -- an expert opinion.

Expert opinion on pharmacotherapy, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.